16
Participants
Start Date
August 10, 2023
Primary Completion Date
April 11, 2024
Study Completion Date
April 11, 2024
Beta-hydroxybutyrate
Each subject receive Beta-hydroxybutyrate 300mg/kg x 3 for five days. After the treatment period effect variables will be examined.
Placebo
Each subject receive a placebo drink 3 x day for five days. After the treatment period effect variables will be examined.
The University Clinic of Nephrology and Hypertension, Herning
Gødstrup Hospital
OTHER